
Cardiovascular Systems CSII
Quarterly report 2022-Q4
added 02-09-2023
Cardiovascular Systems Cash and Cash Equivalents 2011-2026 | CSII
Annual Cash and Cash Equivalents Cardiovascular Systems
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 66.4 M | 71.1 M | 185 M | 74.2 M | 116 M | 108 M | 60.6 M | 83.8 M | 127 M | 67.9 M | 35.5 M | 21.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 185 M | 21.2 M | 84.8 M |
Quarterly Cash and Cash Equivalents Cardiovascular Systems
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59.8 M | 62.8 M | 66.4 M | 67 M | 65.9 M | 66.9 M | 71.1 M | 71.1 M | 73.8 M | 92.7 M | 73.8 M | 69.6 M | 65.5 M | 58.9 M | 65.5 M | 58.9 M | 119 M | 113 M | 119 M | 113 M | 107 M | 105 M | 107 M | 105 M | 79.3 M | 58.2 M | 79.3 M | 58.2 M | 62.2 M | 76.7 M | 65.3 M | 76.7 M | 101 M | 116 M | 101 M | 116 M | 147 M | 63.2 M | 147 M | 63.2 M | 29.2 M | 32.2 M | 29.2 M | 32.2 M | 24.6 M | 22.7 M | 24.6 M | 22.7 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 147 M | 22.7 M | 75.1 M |
Cash and Cash Equivalents of other stocks in the Medical devices industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aziyo Biologics
AZYO
|
19.3 M | - | 1.37 % | $ 20.5 M | ||
|
Bruker Corporation
BRKR
|
183 M | $ 39.08 | -1.83 % | $ 5.82 K | ||
|
Conformis
CFMS
|
48.7 M | - | - | $ 16.4 M | ||
|
Cutera
CUTR
|
144 M | - | -10.19 % | $ 1.99 M | ||
|
Acutus Medical
AFIB
|
19.2 M | - | -26.83 % | $ 2.62 M | ||
|
Dynatronics Corporation
DYNT
|
326 K | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
101 M | - | - | $ 10.2 M | ||
|
Allied Healthcare Products
AHPI
|
3.32 M | - | 3.58 % | $ 2.21 M | ||
|
Second Sight Medical Products
EYES
|
18.4 M | - | -0.97 % | $ 54.4 M | ||
|
Cognyte Software Ltd.
CGNT
|
78.6 M | $ 7.79 | 3.73 % | $ 559 M | ||
|
FONAR Corporation
FONR
|
46.8 M | $ 18.49 | -0.38 % | $ 121 M | ||
|
AdaptHealth Corp.
AHCO
|
106 M | $ 9.41 | -2.39 % | $ 1.27 B | ||
|
Apollo Endosurgery
APEN
|
57 M | - | - | $ 475 M | ||
|
CONMED Corporation
CNMD
|
40.8 M | $ 43.34 | -5.35 % | $ 1.35 B | ||
|
IRIDEX Corporation
IRIX
|
7.03 M | $ 1.45 | 2.84 % | $ 23.4 M | ||
|
IRadimed Corporation
IRMD
|
52.2 M | $ 104.65 | 0.88 % | $ 1.33 B | ||
|
Avinger
AVGR
|
5.28 M | - | -20.74 % | $ 369 K | ||
|
AxoGen
AXGN
|
35.5 M | $ 29.78 | -2.84 % | $ 1.37 B | ||
|
Apyx Medical Corporation
APYX
|
43.7 M | $ 3.18 | -3.05 % | $ 110 M | ||
|
Axonics Modulation Technologies
AXNX
|
239 M | - | - | $ 3.31 B | ||
|
Accuray Incorporated
ARAY
|
57.4 M | $ 0.52 | -5.19 % | $ 53.4 M | ||
|
Pulmonx Corporation
LUNG
|
70.9 M | $ 1.53 | - | $ 59.8 M | ||
|
Neovasc
NVCN
|
51.5 M | - | - | $ 111 M | ||
|
Medigus Ltd.
MDGS
|
8.75 M | - | 10.28 % | $ 55.5 M | ||
|
Medtronic PLC
MDT
|
2.22 B | $ 96.73 | -1.38 % | $ 124 B | ||
|
Cytosorbents Corporation
CTSO
|
3.28 M | $ 0.79 | 5.78 % | $ 43 M | ||
|
Align Technology
ALGN
|
1.04 B | $ 182.92 | -3.23 % | $ 13.7 B | ||
|
Inari Medical
NARI
|
60.2 M | - | - | $ 4.23 B | ||
|
Butterfly Network
BFLY
|
88.8 M | $ 3.73 | -3.37 % | $ 790 M | ||
|
BIOLASE
BIOL
|
6.57 M | - | -13.19 % | $ 166 K | ||
|
EDAP TMS S.A.
EDAP
|
24.7 M | $ 3.96 | -3.54 % | $ 148 M | ||
|
Abbott Laboratories
ABT
|
8.52 B | $ 113.53 | -0.49 % | $ 198 B | ||
|
NuVasive
NUVA
|
249 M | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
94.5 M | - | - | $ 217 M | ||
|
Orthofix Medical
OFIX
|
82 M | $ 13.02 | -2.62 % | $ 516 M | ||
|
BioSig Technologies
BSGM
|
142 K | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
1.96 B | $ 73.88 | -3.07 % | $ 109 B | ||
|
PAVmed
PAVM
|
19.6 M | $ 9.94 | -0.4 % | $ 71.9 M | ||
|
Penumbra
PEN
|
187 M | $ 340.23 | -0.61 % | $ 13.2 B |